menu
    • menu

    Company profile for Odyssey Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.Odyssey has developed a strategy to create a portfolio of medicines that will go beyond the boundaries of today. By focusing on key signaling nodes that drive disease, we aim to achieve optimal product profiles and min...
    At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine.Odyssey has developed a strategy to create a portfolio of medicines that will go beyond the boundaries of today. By focusing on key signaling nodes that drive disease, we aim to achieve optimal product profiles and minimize biologic attrition while maximizing the clinical benefit of each therapeutic.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Odyssey TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    301 Binney Street, Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://odysseytx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/odyssey-tx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Odyssey Therapeutics Names Dennis Dean, Ph.D. as EVP
    Odyssey Therapeutics Names Dennis Dean, Ph.D. as EVP

    11 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251111185634/en/Odyssey-Therapeutics-Appoints-Dennis-Dean-Ph.D.-as-Executive-Vice-President-Head-of-Non-Clinical-Development

    BUSINESSWIRE
    11 Nov 2025
    Share Share
    Odyssey Therapeutics Appoints Pharma Leader Nia Tatsis to Board
    Odyssey Therapeutics Appoints Pharma Leader Nia Tatsis to Board

    09 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-09/odyssey-therapeutics-appoints-pharmaceutical-leader-nia-tatsis-phd-to-its-board-of-directors

    PHARMIWEB
    09 Oct 2025
    Share Share
    Odyssey Rebounds Off Failed IPO With $213M Series D
    Odyssey Rebounds Off Failed IPO With $213M Series D

    10 Sep 2025

    // BIOSPACE

    https://www.biospace.com/business/odyssey-rebounds-off-failed-ipo-with-213m-series-d

    BIOSPACE
    10 Sep 2025
    Share Share
    Odyssey Therapeutics Appoints Jason as Chief Financial Officer
    Odyssey Therapeutics Appoints Jason as Chief Financial Officer

    08 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108467996/en

    BUSINESSWIRE
    08 Jan 2025
    Share Share
    Odyssey and Terray Therapeutics Collaborate on 1st-in-Class Therapy
    Odyssey and Terray Therapeutics Collaborate on 1st-in-Class Therapy

    28 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241028561053/en

    BUSINESSWIRE
    28 Oct 2024
    Share Share
    Odyssey Therapeutics Shares Data on RIPK2 Inhibitor at ACG
    Odyssey Therapeutics Shares Data on RIPK2 Inhibitor at ACG

    27 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241027319044/en

    BUSINESSWIRE
    27 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search